Proto Script Pharmaceutical (PSCR) Stock Analysis & Winston Score

Proto Script Pharmaceutical Corp. is a small specialty company that provides pharmaceutical compounding and related services. Compounding means mixing or preparing custom medications tailored to individual patients when standard commercial drugs do not meet their needs. The company serves patients, healthcare providers, and pharmacies, operating within the specialty business services segment of the industrials sector. The company generates revenue primarily through service fees and product sales tied to its compounding operations, which explains its relatively high gross margin of 71.5%. However, it is currently spending more than it earns at the operating level, reflected in its negative operating margin of nearly 38%, meaning it is not yet profitable on a day-to-day basis. The main risk the business faces is regulatory scrutiny, as pharmaceutical compounding is closely monitored by the FDA and state pharmacy boards, and any compliance failures could significantly disrupt operations or limit its ability to grow.